Patents by Inventor Eliot Slovin

Eliot Slovin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Non-Polymeric Lipophilic Pharmaceutical Implant Compositions for Intraocular Use
    Publication number: 20070184089
    Abstract: Solid or semi-solid intraocular implant compositions are disclosed. The compositions contain a lipophilic compound but lack a polymeric ingredient.
    Type: Application
    Filed: April 3, 2007
    Publication date: August 9, 2007
    Applicant: ALCON, INC.
    Inventors: Janet Howie, Eliot Slovin, David Marsh, Bhagwati Kabra
  • Methods for preparing biodegradable microparticle formulations containing pharmaceutically active agents
    Publication number: 20070053989
    Abstract: This invention is directed to an apparatus and method for producing microparticles comprising pharmacologically active agents and biodegradable polymers. The apparatus includes a spinning disk containing a reservoir in the center thereof and a flat inclined surface. The apparatus optionally includes serrations and/or a flat surface beneath the periphery of the disk that is parallel to the rotational axis of the disk. The invention is also directed to a method for producing microparticles containing pharmacologically active agents, using the spinning disk apparatus. Formulations containing ophthalmically active agents are provided. Formulations exhibiting zero order release rates are also described.
    Type: Application
    Filed: September 7, 2005
    Publication date: March 8, 2007
    Applicant: Southwest Research Institute
    Inventors: Joseph Persyn, Joseph McDonough, Neal Vail, Darren Barlow, Albert Zwiener, Eliot Slovin
  • Apparatus for preparing biodegradable microparticle formulations containing pharmaceutically active agents
    Publication number: 20070054002
    Abstract: This invention is directed to an apparatus and method for producing microparticles comprising pharmacologically active agents and biodegradable polymers. The apparatus includes a spinning disk containing a reservoir in the center thereof and a flat inclined surface. The apparatus optionally includes serrations and/or a flat surface beneath the periphery of the disk that is parallel to the rotational axis of the disk. The invention is also directed to a method for producing microparticles containing pharmacologically active agents, using the spinning disk apparatus. Formulations containing ophthalmically active agents are provided. Formulations exhibiting zero order release rates are also described.
    Type: Application
    Filed: September 7, 2005
    Publication date: March 8, 2007
    Applicant: Southwest Research Institute
    Inventors: Joseph Persyn, Joseph McDonough, Neal Vail, Darren Barlow, Albert Zwiener, Eliot Slovin
  • Pharmaceutical formulations exhibiting improved release rates
    Publication number: 20070053990
    Abstract: This invention is directed to an apparatus and method for producing microparticles comprising pharmacologically active agents and biodegradable polymers. The apparatus includes a spinning disk containing a reservoir in the center thereof and a flat inclined surface. The apparatus optionally includes serrations and/or a flat surface beneath the periphery of the disk that is parallel to the rotational axis of the disk. The invention is also directed to a method for producing microparticles containing pharmacologically active agents, using the spinning disk apparatus. Formulations containing ophthalmically active agents are provided. Formulations exhibiting zero order release rates are also described.
    Type: Application
    Filed: September 7, 2005
    Publication date: March 8, 2007
    Applicant: Southwest Research Institute
    Inventors: Joseph Persyn, Joseph McDonough, Neal Vail, Darren Barlow, Albert Zwiener, Eliot Slovin
  • Process for the stereospecific preparation of 24(R),25- and 24(S),25-dihydroxycholecalciferol and novel intermediates used therefor
    Patent number: 4758382
    Abstract: A novel process for the stereospecific preparation of a 24(R),25- and 24(S),25-dihydroxycholecalciferol. Also provided are novel intermediates used in the above process, being 22-p-toluenesulfonyl derivatives of 23,24,25,26,27-pentanorcholecalciferol and of 24(R)- and 24(S),25-dihydroxycholecalciferol.
    Type: Grant
    Filed: December 22, 1986
    Date of Patent: July 19, 1988
    Assignee: Teva Pharmaceutical Industries Ltd.
    Inventors: Jeffrey Sterling, Ben-Zion Weiner, Dinora Barasch, Danielle Hirsch, Eliot Slovin